Awareness of personalised medicine in cancer patients
Awareness of personalised medicine in cancer patients
Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial
Highlights from the 17th International Conference on Cancer Nursing
Educational programmes for oncology nurses
Oncology nursing and survivorship
Smoking cessation in the Czech Republic
Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication
Cost effective care and the state of oncology in India
Highlights from the 2012 NCID Meeting
Cancer care in Cameroon and treatment options